GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » EV-to-FCF

Merck KGaA (Merck KGaA) EV-to-FCF : 41.49 (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Merck KGaA's Enterprise Value is $78,611 Mil. Merck KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $1,895 Mil. Therefore, Merck KGaA's EV-to-FCF for today is 41.49.

The historical rank and industry rank for Merck KGaA's EV-to-FCF or its related term are showing as below:

MKKGY' s EV-to-FCF Range Over the Past 10 Years
Min: 13.26   Med: 32.03   Max: 51.67
Current: 41.95

During the past 13 years, the highest EV-to-FCF of Merck KGaA was 51.67. The lowest was 13.26. And the median was 32.03.

MKKGY's EV-to-FCF is ranked worse than
69.47% of 511 companies
in the Drug Manufacturers industry
Industry Median: 22.05 vs MKKGY: 41.95

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-28), Merck KGaA's stock price is $32.25. Merck KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.398. Therefore, Merck KGaA's PE Ratio for today is 23.07.


Merck KGaA EV-to-FCF Historical Data

The historical data trend for Merck KGaA's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA EV-to-FCF Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.83 37.61 33.78 35.66 40.08

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.66 35.58 36.60 43.55 40.08

Competitive Comparison of Merck KGaA's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Merck KGaA's EV-to-FCF falls into.



Merck KGaA EV-to-FCF Calculation

Merck KGaA's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=78611.423/1894.742
=41.49

Merck KGaA's current Enterprise Value is $78,611 Mil.
Merck KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,895 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA  (OTCPK:MKKGY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Merck KGaA's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.25/1.398
=23.07

Merck KGaA's share price for today is $32.25.
Merck KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.398.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Merck KGaA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Merck KGaA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (Merck KGaA) Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (Merck KGaA) Headlines

From GuruFocus